MimyX Cream is a fragrance free, preservative free, water-based emulsion formulated for managing signs and symptoms of various dermatoses. MimyX Cream helps to relieve the dry, waxy skin by maintaining a moist wound & skin environment, which is beneficial to the healing process.

Contraindications: MimyX Cream is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.
Warnings: In radiation therapy, MimyX Cream may be applied as indicated by the treating Radiation Oncologist. Do not apply 4 hours prior to a radiation session.
Precautions and Observations: • MimyX Cream is for external use only. • MimyX Cream does not contain a sunscreen and should not be used prior to extended exposure to the sun. • If clinical signs of infection are present, appropriate treatment should be initiated; use of MimyX Cream may be continued during the anti-infective therapy. • If the condition does not improve within 10-14 days, consult a physician. • Keep this and other similar products out of the reach of children. • MimyX Cream may dissolve fuchsin when this dye is used to define the margins of the radiation fields to be treated.
References: 1. Zerweck C, Fraser JM, Grove GL. Efficacy of S236 cream in promoting barrier repair of razor-induced skin trauma. Presented at: 64th Annual Meeting of the American Academy of Dermatology; March 2006; San Francisco, Calif. Poster 805. 2. Asin Llorca M, Dorado Bris JM, Saenz de Santamaria MC, Aneri Mas V, Garay Arconada, Perez Muinelo A. Evaluation of the activity of a moisturizing and restoring-action preparation, with lamellar structure, as adjuvant in the treatment of atopic dermatitis and xerotic skin. Rev Intern Dermatol Dermocosm. 2003;6:425-430. 3. Jorizzo JL. Lamellar preparations as adjunctive therapy in the treatment of atopic dermatitis. Presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 2005; New Orleans, La. Poster 721. 4. Eberlein-Koenig B, Eicke C, Reinhardt H-W, Ring J. Adjuvant treatment of atopic eczema: Assessment of an emollient containing N-palmitoylethanolamide (ATOPA Study). Presented at: 64th Annual Meeting of the American Academy of Dermatology; March 2006; San Francisco, Calif. Poster 821. 5. Kemeny L. A comparison of S236 cream to hydrocortisone 1% cream in the treatment of mild to moderate atopic dermatitis. Presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 2005; New Orleans, La. Poster 708.

THE INFORMATION CONTAINED IN THE WEBSITE IS NOT INTENDED TO SERVE AS A SUBSTITUTE FOR INFORMED MEDICAL ADVICE.